	Generative AI in antibody engineering: emerging concepts and translational bottlenecks in lung cancer. In Silico Pharmacol An X, Li F, Xia C, Li Y, Li H, Xie F. PMID: 42438781 [PubMed]
	From pulmonary embolism to small intestinal neuroendocrine tumor: A new diagnostic perspective. J Int Med Res Wu Z, Huang H, Li A, Zheng X, Zheng Z, He X, Jin T. PMID: 42438425 [PubMed - indexed for MEDLINE]
	Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High-Risk Individuals in Australia. Med J Aust Rankin NM, Zosel R, Whop LJ, Maddox R, McWilliams A, Siemienowicz M, Emery J, Lantin MAR, Bartlett G, Wolfe M, Diaz A, Anderson K, Liu L, Toms C, McDermott S, Bligh P, Chalke J, Melsom S, Nightingale CE, Brown A, Pope S, Brotherton J, Fidler A, Itel M, Brooke M, Pascoe DM, Brims F, Leong TL, Stone E, Keefe D, Milch V. PMID: 42438375 [PubMed - indexed for MEDLINE]
	Surgery after induction immuno-chemotherapy in stage III-N3 non-small cell lung cancer: a single-center retrospective cohort study. Interdiscip Cardiovasc Thorac Surg Zeng X, Zhou Q, Wang S, Han L, Zhang P, Shen Z, Zhou Y, Zhang J. PMID: 42438150 [PubMed - as supplied by publisher]
	YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer: Research Summary. JAMA PMID: 42437324 [PubMed - as supplied by publisher]
	YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer: A Randomized Clinical Trial. JAMA Akerboom B, Martens ESL, Stals MAM, Brouwer RE, Coppens M, Costantino G, Couturaud F, van Dooren YPA, van der Griend R, Hugli O, Jiménez D, Kamphuisen PW, El Kharbouchi O, Kroft LJM, Leentjens J, Maas ML, van Mens TE, Mahé I, van Meer OA, Out M, Pola R, Raskin J, Righini M, Sprenger RA, Kaptein FHJ, Talerico R, Tritschler T, Ten Wolde M, Klok FA, Huisman MV, Hydra Study Investigators. PMID: 42437322 [PubMed - as supplied by publisher]
	Neoantigens in Cancer Immunotherapy: An Overview with a Focus on Non-small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma. Iran J Allergy Asthma Immunol Eskandari-Malayeri F, Shekarchian S, Mortaz E. PMID: 42437308 [PubMed - indexed for MEDLINE]
	HPLC-HRMS and interpretable machine learning decipher serum lipidomic signatures in NSCLC. PeerJ Tang C, Lyu J, Huang J, Zhang X, Mou C, Liu Y, Ni S, Liu Y, Li L, Xiao L, Zhang S, Zheng X. PMID: 42437038 [PubMed - indexed for MEDLINE]
	Targeting Lung Cancer Metabolism: Therapeutic Opportunities and Challenges. Adv Exp Med Biol Freitas-Dias C, Mendes C. PMID: 42435178 [PubMed - indexed for MEDLINE]
	LDHA, BIK, and CNIH4 Are Diagnostic Markers of Endoplasmic Reticulum Stress in Lung Cancer Comorbid With Sepsis: Integrating Machine Learning and Single-Cell Analysis of Immune Signaling. Mediators Inflamm Pan Y, Liu X, Wang J, Yan J. PMID: 42434863 [PubMed - indexed for MEDLINE]
	Optimal treatment strategies for unresectable stage III EGFR-mutated non-small cell lung cancer: a systematic review and Bayesian network meta-analysis. Front Oncol Yang Y, Sun J, Luo T, Liu X, Wang Y. PMID: 42434745 [PubMed]
	From pancreatic ductal adenocarcinoma to non-small cell lung cancer: daraxonrasib in the RASolute 302 trial - a pan-RAS(ON) breakthrough or the next evolution in targeting diverse oncogenic RAS variants? Ann Med Surg (Lond) Qaseem M, Ali MS, Ali S, Hasan AH. PMID: 42433811 [PubMed]
	Comparison of dosimetric parameters and delivery accuracy between conformal radiotherapy-intensity modulated radiotherapy-combined and intensity-modulated radiotherapy planning for central lung cancer patients receiving stereotactic body radiotherapy. Quant Imaging Med Surg Shao Y, Guo J, Duan Y, Huang Y, Feng A, Chen H, Wang H, Gu H, Shen Z, Xu Z. PMID: 42433523 [PubMed]
	Quantifying the impact of slice thickness on cardiovascular risk stratification in lung cancer screening: a multi-center "RESCUE" study. Quant Imaging Med Surg Wang M, Zhang J, Zhu R, Gu J, Fan L, Chen Q. PMID: 42433512 [PubMed]
	Efficacy and safety of Programmed Death Ligand 1 inhibitors versus Programmed Death 1 inhibitors in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials. PeerJ Dang C, Li J, Chen H, Luo Z. PMID: 42433386 [PubMed - indexed for MEDLINE]
	Assessment of tumor mutation burden based on whole-exome sequencing of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid in advanced non-small cell lung cancer treated with pembrolizumab: a prospective, multicenter, observational study. Transl Lung Cancer Res Kim H, Hur J, Kim WS, Kim IA, Park D, Oh IJ, Noh SJ, Bang H, Lee KY. PMID: 42433255 [PubMed]
	Over- and underscreening for lung cancer. Transl Lung Cancer Res Cao H, Zhang Y, Fu F, Chen H. PMID: 42433251 [PubMed]
	Consolidation thoracic radiotherapy following quadruple induction with benmelstobart, anlotinib, and chemotherapy for extensive-stage small cell lung cancer: rationale and protocol of a phase II study. Transl Lung Cancer Res Zhou Y, Zhu H, Yang S, Liu J, Yu M, Sun J, Yang C, Cui Y, Liu N. PMID: 42433250 [PubMed]
	Prognostic analysis and beneficiary population exploration of subsequent treatment regimens after third-generation EGFR-TKIs failure in EGFR-mutated advanced non-small cell lung cancer: a retrospective cohort study. Transl Lung Cancer Res Wu Z, Liu T, Yu R, Li J, Hu S, Liu C, Du X, Shi X, Dai Y, Lu L, Ma Y, Jiang Y, Shi Y, Zhou G, Chen C, Shi J, Ding N, Wang X. PMID: 42433249 [PubMed]
	Inconsistent definitions of radical resection in perioperative trials of non-small cell lung cancer: a scoping review. Transl Lung Cancer Res Niedzielska J, Szczepa, Ciarka A, P, Szylberg , Borowczak J, Marja. PMID: 42433245 [PubMed]

Articles 1 - 20 / 160419

Page 1 of 8021



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy